搜尋
BridgeBio Oncology Therapeutics Ord Shs
BBOT添加自選
8.090USD
-0.410-4.82%
收盤 07-31 16:00（美東）報價延遲15分鐘
648.07M總市值
40.07本益比TTM
股東統計
更新時間: 5月7日 週四
更新時間: 5月7日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Cormorant Asset Management, LP
22.32%
BridgeBio Pharma, Inc.
18.21%
Deerfield Management Company, L.P.
6.10%
BC Global Opportunities IX LP
5.45%
Omega Fund Management, LLC
4.11%
其他
43.81%
持股股東
持股股東
佔比
Cormorant Asset Management, LP
22.32%
BridgeBio Pharma, Inc.
18.21%
Deerfield Management Company, L.P.
6.10%
BC Global Opportunities IX LP
5.45%
Omega Fund Management, LLC
4.11%
其他
43.81%
股東類型
持股股東
佔比
Hedge Fund
42.35%
Corporation
26.94%
Investment Advisor/Hedge Fund
11.53%
Venture Capital
10.63%
Investment Advisor
6.23%
Research Firm
0.43%
Individual Investor
0.25%
其他
1.64%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q4
68
54.41M
48.03%
--
2026Q1
98
57.78M
72.13%
-3.79M
2025Q4
73
54.57M
68.22%
+15.19M
2025Q3
72
54.42M
68.03%
+15.72M
2025Q2
49
16.72M
87.47%
-855.66K
2025Q1
43
16.79M
88.78%
-267.82K
2024Q4
41
16.75M
88.56%
+227.86K
2024Q3
36
16.37M
86.59%
-5.42K
2024Q2
33
16.38M
89.02%
+311.06K
2024Q1
31
16.07M
84.98%
+7.80M
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Cormorant Asset Management, LP
17.88M
22.34%
--
--
Dec 31, 2025
BridgeBio Pharma, Inc.
14.59M
18.23%
+784.72K
+5.68%
Oct 10, 2025
Deerfield Management Company, L.P.
4.89M
6.1%
--
--
Dec 31, 2025
BC Global Opportunities IX LP
4.37M
5.45%
+3.27M
+296.89%
Sep 04, 2025
Omega Fund Management, LLC
3.29M
4.11%
--
--
Dec 31, 2025
Wellington Management Company, LLP
2.91M
3.63%
-54.26K
-1.83%
Dec 31, 2025
Alphabet, Inc.
2.82M
3.53%
--
--
Dec 31, 2025
EcoR1 Capital, LLC
2.82M
3.53%
--
--
Dec 31, 2025
Enavate Sciences GP, LLC
2.63M
3.28%
--
--
Dec 31, 2025
Citadel Advisors LLC
2.53M
3.16%
-7.82K
-0.31%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月9日 週二
更新時間: 12月9日 週二
機構名稱
佔比
Tema Oncology ETF
0.26%
Schwab U.S. Small-Cap ETF
0.01%
Schwab U.S. Broad Market ETF
0%
iShares Health Innovation Active ETF
0%
Tema Oncology ETF
佔比0.26%
Schwab U.S. Small-Cap ETF
佔比0.01%
Schwab U.S. Broad Market ETF
佔比0%
iShares Health Innovation Active ETF
佔比0%